present addit detail navig studi avapritinib
gist compani also present modestli updat find ph arrow
studi ret-inhibitor patient thyroid cancer present
reinforc drug competit profil two wholli own approv
oncolog drug continu rate share outperform
link full note
downgrad under-perform lack convers concern pt
see risk appear contribut come light
 compound impact cyclic deceler legaci busi believ
stimul acquir organ growth materi improv margin nt mutual
exclus given cost requir shift view given central
stori put multipl still risk pt
link full note
pleas see addendum report import disclosur
recent host meet boston manag includ cfo scott
goldenberg remain confid high-single/low-double-digit ep compound-annual-growth-rate potenti
see invest dc produc improv unit/cost econom time
view freight sourc potenti margin recoveri stock cheap
ep ev/ebitda potenti compound growth
link full note
rise anti-trust focu googl amazon -- overreact
weekend news report say doj prepar anti-trust investig googl
ftc close examin amazon
read report increment concern game-chang believ
break-up either compani remain unlik
link full note
attend updat data show orr consist
data new median durat respons mo mo mrd-
ug/d dose overal durabl less seen clearli continu
infus limit durabl data set stage extend half-lif
bite weekli dose possibl data
link full note
pg conf book data model question of stock report
print booklet let us know like copi adjust macro reflect lower
 spend alreadi assum minim chang spoke
major coverag past week highlight topic stock head
conf season estimate price tgt updat page
link full note
week chainalytics-cowen freight indic dri van spot rate increas
sequenti indic perhap freight market heat slow winter
spring season view posit readthrough tl logist
compani oper spot market full chart pleas see page
link full note
in-depth report publish quarter compar wireless result
provid increment posit given solid overal financi result
despit worsen video loss although believ latter better reflect
estim less posit nt given strength post fcc approv
pend decis deal takeaway includ
link full note
wireless snapshot includ chart provid overview
 wireless landscap recent quarter present meant
addendum depth wireless quarterli report publish
link full note
biotech thermomet intend provid client view institut
investor sentiment toward biotechnolog sector individu stock upcom
event believ better understand sentiment facilit effect
invest strategi view express base upon team interact
investor month may
link full note
follow initi note friday fda meet offer takeaway cbd
compani present given highli fragment natur cbd categori
swell new categori entrant post passag industri
present regul seem align need formal regulatori
framework like requir increment legisl
link full note
would buyer ci share detail analyst day reinforc belief
segment grow y/i acceler growth
along ci long-term growth expect segment stronger
expect give us greater confid abil hit target ep
ep find share attract
link full note
encourag preliminari result solid tumor
present poster present report preliminari result
solid tumor view efficaci data encourag note
posit differenti safeti profil compar nivolumab believ
data continu justifi advanc probodi platform oncolog
link full note
present updat data combin keytruda
treatment head neck cancer orr continu somewhat ahead
produc keytruda monotherapi suggest addit activ nonetheless
futur develop depend upon partner longer focu
investor continu think under-valued heplisav
link full note
increment posit passport transact follow analyst
day compani provid addit clariti give us greater comfort deal
uniqu opportun repres shift strategi believ
limit downsid invest believ intend maintain
stake long-term
link full note
provid initi view
within portfolio fprx proprietari novel io asset provid
first look clinic data first-in-class antibodi initi
phase data provid reassur manag calm confid on-going
progress program clinic data point continu build head
esmo respect outperform
link full note
asco trilaciclib sclc data updat file plan pipelin track
gthx asco updat includ increment data sclc enrich data set
expect support nda file trilaciclib myelopreserv benefit
convers manag bolster confid tone gthx
interact agenc thu far continu time progress addit trial
help build visibl pipelin asset outperform
link full note
updat thought glu tmt confer univers launch
glu ceo nick earl spoke cowen tmt confer last wednesday day
compani launch new titl univers continu rank
top invest idea think recent pullback make attract entri point
link full note
report data combin mirv avastin
academ poster highlight mirv gemcitabin believ data increment
posit note investor focu remain development pathway
mirvetuximab monotherapi new pivot trial anticip start
link full note
phase data daiichi releas poster yesterday
demonstr activ nsclc daiichi disclos pursu develop
mtnbc opinion appear viabl though data preliminari
defin posit vs sacituzumab continu believ under-valued
potenti sacituzumab
link full note
present two poster innovatil- trial show
encourag efficaci til melanoma cerviv cancer stock weak
friday may driven articl suggest prior respond
progress believ sell-off unwarr view data updat
posit
link full note
host investor dinner mersana manag team discuss
poster well anticip next step corpor mileston
overal believ data increment posit support
develop dose escal continu final dose level
current enrol expans cohort plan
link full note
initi mist outperform rate price target
promis lead candid etripamil intranas acut treatment psvt
think strong class efficaci psvt bode well success
us approv model ww peak sale us also
see addit upsid potenti indic afib angina
link full note
updat cr rate improv melanoma
cr rate nktr follow-up melanoma cohort
indic deepen respons time nktr messag proffer
favor food thought consid bempeg prospect context nivo
ipi benchmark ahead pivot result trove data addit
tumor type keep debat aliv outperform
link full note
encourag activ advanc ovarian biliari cancer
nucana present updat ovarian cancer biliari
tract cancer btc view initi efficaci safeti data studi
promis limit low patient number next key mileston includ fda
feedback start phase studi acelarin btc data
protid
link full note
initi engineering/servic growth stori
initi coverag well manag engineering/servic hybrid play
focus enhanc grow servic busi via rate outperform
pt tev/ebitda line peer
link full note
cowen tmt confer way revenu
host firesid chat jason starr vice-president investor relat
tmt confer base discuss increas confid
surpass revenu maintain
margin continu believ share look attract current level given
growth margin reiter top pick pt
link full note
cowen tmt confer management remain excit opportun ahead
host firesid chat jeff kalowski cfo andrew burton presid
tmt confer core pillar experienc strong growth
well posit capit remain opportun within end-market
follow discuss remain confid deliv propos
growth reiter top pick pt
link full note
cautiou analyst day though expect target reiter
expect rd reaffirm capital-expenditure organ target though potenti
 could suggest ex divest come prior guidanc rd could
address concern resourc base highlight project backlog sourc
use cash impli divest enabl repurchas reduc
target base annual
link full note
igv softwar index break posit streak
seen greater season recent earn come across data
point around macro pressur spend env combin fact
june season weak month igv next season strong period
aug-oct would unsurpris see choppi
link full note
takeaway wia tmus/ deal posit tower
recent attend wia conf orlando fl believ tmus/ deal
approv drive upsid tower estim also like help
enabl increas wireless competit could potenti includ emerg
new fourth carrier recent report suggest continu posit lt
view tower despit trade all-tim high
link full note
cowen tmt confer highlight firesid chat cfo
host firesid chat cfo dave rockvam tmt confer
discuss present cfo rockvam highlight improv posit
post appriv acquisit benefit deal reach
origin recogn think well-posit capit
expand opportun maintain outperform pt
link full note
 china squar last week shangri-la dialogu dod releas
new indo-pacif strategi emphas strategi region call
china russia long-term challeng maintain geopolitical/militari
competit remain even -china trade solv china continu
influenc defens strategi spend program
link full note
june hous appropri includ cannabi measur spend
hous appropri subcommitte today consid spend packag
would protect bank provid servic cannabi compani compli
state law see open cannabi bank appli
justic depart fbi also drop ban dc regul cannabi sale
hike sec fund enforc
link full note
oral argument texa case set juli three judg panel
announc around juli like bring case back headlin texa
look like enact measur limit surpris medic bill may templat
state fed co enact co-pay cap insulin also call
link full note
werewolv london trump europ china tariff delay compani retali
trump europ week uk day franc ireland
in-bound china good tariff extend june june larg technic reason
believ like reflect delay custom
china white paper blame us current impass unreli entiti list retali
like week
histor week anniversari tiananmen squar d-day
link full note
june white hous prep execut order healthcar price
white hous expect soon releas execut order improv price
transpar broader healthcar market limit pharmaceut
link full note
import disclosur inform relat cowen washington research group
